Table 3.
Cerebrovascular accident after treatment
| Patient | Age (yr)a) | Sex | Tumor type | RT dose (cGy) | Time since RT (yr) | Hormone normalization | Stroke lesion | Stroke risk factors |
|---|---|---|---|---|---|---|---|---|
| 1 | 53 | M | Secreting (GH) | 5,400 | 5.2 | Yes | Pons | DM |
| 2 | 29 | F | Secreting (PRL) | 5,400 | 3.8 | Yes | Pons | DM |
| 3 | 68 | F | Non-secreting | 5,400 | 8.5 | - | Midbrain | - |
| 4 | 59 | M | Non-secreting | 5,220 | 2.3 | - | Unknown | HTN |
| 5 | 66 | M | Non-secreting | 4,500 | 6.0 | - | Right inferior cerebellum | Arrhythmia |
| 6 | 48 | F | Non-secreting | 5,400 | 5.5 | - | Left frontal lobe (subcortical area) | Arrhythmia |
RT, radiotherapy; M, male; F, female; GH, growth hormone; DM, diabetes mellitus; PRL, prolactin; HTN, hypertension; Arrhythmia, atrial fibrillation.
a)
Age at radiotherapy treatment.